Haak H R, van Seters A P, Moolenaar A J, Fleuren G J
Department of Internal Medicine, Diaconessenhuis, Eindhoven, The Netherlands.
Eur J Cancer. 1993;29A(7):1036-8. doi: 10.1016/s0959-8049(05)80219-9.
The presence of P-glycoprotein, associated with multiple drug resistance and present in the normal adrenal cortex, was studied in 15 cases of adrenocortical carcinoma. P-glycoprotein was found in eight tumours; no correlation was found with clinical presentation, steroid production or histological index. 10 patients received mitotane. Remarkably, 3 patients with P-glycoprotein-positive tumours achieved complete remission. On the other hand, 2 patients with P-glycoprotein-negative tumours showed progression of the disease despite mitotane treatment. These findings suggest that the expression of P-glycoprotein in adrenocortical carcinoma is not related to clinical manifestations, steroid production, histological index or response to mitotane therapy.
研究了15例肾上腺皮质癌中与多药耐药相关且存在于正常肾上腺皮质中的P-糖蛋白。在8个肿瘤中发现了P-糖蛋白;未发现其与临床表现、类固醇生成或组织学指标相关。10例患者接受了米托坦治疗。值得注意的是,3例P-糖蛋白阳性肿瘤患者实现了完全缓解。另一方面,2例P-糖蛋白阴性肿瘤患者尽管接受了米托坦治疗,但疾病仍进展。这些发现表明,肾上腺皮质癌中P-糖蛋白的表达与临床表现、类固醇生成、组织学指标或对米托坦治疗的反应无关。